What is it about?

Urocortin (UCN) is a anti-inflammatory neuropeptide which protects cardiomyocytes against ischemia-reperfusion injury, and alleviates endotoxin-induced injury to dopaminergic neurons. Intracerebral hemorrhage (ICH), which causes injury to the brain, remains a major medical problem. We discover that UCN also reduces damages caused by ICH if it were given to the ICH rats within 1 hour. ICH was induced by an infusion of bacteria collagenase VII-S into the right striatum of anesthetized rats. At 1 hour after induction of ICH, UCN (5 g) was infused into the right lateral ventricle. Post-treatment of UCN did not affect the hemorrhagic volume on 1 day after ICH, but significantly reduced the hemorrhage-induced lesion on 3 (P<0.01) and 7 (P<0.05) days after ICH, respectively. Brain edema (P<0.05) and blood-brain barrier permeability (P<0.05) on 3 days after ICH also reduced significantly in rats receiving post-treatment of UCN. Moreover, the neurological abnormalities caused by ICH improved throughout the 1 to 7 days in rats receiving post-treatment of UCN.

Featured Image

Why is it important?

ICH is a devastating disease without any cure. Our finding suggests that UCN may work in reducing the severity of ICH injury if given in time.

Perspectives

UCN has been tested on human suffering from heart diseases. The safety of his neuropeptide has been well studied. We hope to test it on patients suffering from various brain injuries in the very near future.

Associate Professor Cheng-Yoong Pang
Hualien Tzu Chi Hospital, Tzu Chi Medical Foundation

Read the Original

This page is a summary of: Therapeutic benefit of urocortin in rats with intracerebral hemorrhage, Journal of Neurosurgery, January 2012, Journal of Neurosurgery Publishing Group (JNSPG),
DOI: 10.3171/2011.8.jns101637.
You can read the full text:

Read

Contributors

The following have contributed to this page